; and research institutions. (B) Publish a comprehensive list of Federal funding resources available to States for research on opioid abuse. (C) Analyze causes and trends behind opioid addiction and pain management. (D) Evaluate the effectiveness of Federal programs for opioid abuse reduction, including opioid treatment programs and medicated-assisted treatments. (E) Evaluate whether any Federal programs for opioid abuse reduction are duplicative. (F) Evaluate the extent to which Federal grants for the implementation of opioid abuse prevention strategies are successful in addressing opioid abuse in local communities. (G) Provide recommendations to health care providers on alternatives to opioids for pain management and other areas in which health care providers can improve with respect to treating or preventing opioid abuse. (H) Analyze opioid prescription guidelines, the different types of opioids prescribed by health care providers, and the use of medicated-assisted treatments. (I) Compare the rate of opioid abuse in veterans receiving health care through the Department of Veterans Affairs with the rate of opioid abuse in the general population. (J) Compare opioid abuse trends and prevention and treatment strategies in different regions and populations of the United States and determine whether certain strategies are more effective than others. (K) Analyze to what extent Federal prevention and treatment strategies for opioid abuse are aligned with State and local prevention and treatment strategies. (c) Reports (1) Initial report Not later than one year after the date of the enactment of this section, the Federal Coordinator shall submit to Congress an initial report on the results of any analysis, evaluation, or comparison conducted under subsection (b)(3). (2) Updated report Not later than five years after the date of the enactment of this section, the Federal Coordinator shall submit to Congress a report that provides updates with respect to any results submitted in the initial report under paragraph (1).